methyldopa 250mg tablets
alliance healthcare (distribution) ltd - methyldopa (anhydrous) - oral tablet - 250mg
methyldopa 125mg tablets
viatris uk healthcare ltd - methyldopa (anhydrous) - oral tablet - 125mg
methyldopa 250mg tablets
viatris uk healthcare ltd - methyldopa (anhydrous) - oral tablet - 250mg
methyldopa 500mg tablets
viatris uk healthcare ltd - methyldopa (anhydrous) - oral tablet - 500mg
methyldopa 250mg tablets
sigma pharmaceuticals plc - methyldopa (anhydrous) - oral tablet - 250mg
methyldopa 250mg tablets
phoenix healthcare distribution ltd - methyldopa (anhydrous) - oral tablet - 250mg
methyldopa 250mg tablets
genesis pharmaceuticals ltd - methyldopa (anhydrous) - oral tablet - 250mg
methyldopa 125mg tablets
bristol laboratories ltd - methyldopa (anhydrous) - oral tablet - 125mg
methyldopa tablet, film coated
physicians total care, inc. - methyldopa (unii: 56lh93261y) (methyldopa - unii:56lh93261y) - methyldopa 250 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.
methyldopa tablet film coated
teva pharmaceuticals usa inc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg